Cargando…

Oligodendrocyte‐specific deletion of FGFR2 ameliorates MOG(35‐55)‐induced EAE through ERK and Akt signalling

Fibroblast growth factors (FGFs) and their receptors (FGFRs) are involved in demyelinating pathologies including multiple sclerosis (MS). In our recent study, oligodendrocyte‐specific deletion of FGFR1 resulted in a milder disease course, less inflammation, reduced myelin and axon damage in EAE. The...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kamali, Salar, Rajendran, Ranjithkumar, Stadelmann, Christine, Karnati, Srikanth, Rajendran, Vinothkumar, Giraldo‐Velasquez, Mario, Berghoff, Martin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8018040/ https://www.ncbi.nlm.nih.gov/pubmed/33103299 http://dx.doi.org/10.1111/bpa.12916

Ejemplares similares

Oligodendrocyte-Specific Deletion of FGFR1 Reduces Cerebellar Inflammation and Neurodegeneration in MOG(35-55)-Induced EAE
por: Rajendran, Ranjithkumar, et al.
Publicado: (2021)

Effects of FGFR Tyrosine Kinase Inhibition in OLN-93 Oligodendrocytes
por: Rajendran, Ranjithkumar, et al.
Publicado: (2021)

Interferon Beta-1a versus Combined Interferon Beta-1a and Oligodendrocyte-Specific FGFR1 Deletion in Experimental Autoimmune Encephalomyelitis
por: Rajendran, Ranjithkumar, et al.
Publicado: (2022)

FGF/FGFR Pathways in Multiple Sclerosis and in Its Disease Models
por: Rajendran, Ranjithkumar, et al.
Publicado: (2021)

Myelin Oligodendrocyte Glycoprotein (MOG(35-55)) Induced Experimental Autoimmune Encephalomyelitis (EAE) in C57BL/6 Mice
por: Bittner, Stefan, et al.
Publicado: (2014)

Characterization of myelin oligodendrocyte glycoprotein (MOG)(35–55)-specific CD8(+) T cells in experimental autoimmune encephalomyelitis
por: Peng, Yong, et al.
Publicado: (2019)

Arg Deficiency Does not Influence the Course of Myelin Oligodendrocyte Glycoprotein (MOG35-55)-induced Experimental Autoimmune Encephalomyelitis
por: Jacobsen, Freja Aksel, et al.
Publicado: (2016)

Myelin oligodendrocyte glycoprotein (MOG(35-55))-induced experimental autoimmune encephalomyelitis is ameliorated in interleukin-32 alpha transgenic mice
por: Yun, Jaesuk, et al.
Publicado: (2015)

Photobiomodulation Induced by 670 nm Light Ameliorates MOG35-55 Induced EAE in Female C57BL/6 Mice: A Role for Remediation of Nitrosative Stress
por: Muili, Kamaldeen A., et al.
Publicado: (2013)

Immunodominant T-cell epitopes of MOG reside in its transmembrane and cytoplasmic domains in EAE
por: Shetty, Aparna, et al.
Publicado: (2014)

Spontaneous relapsing-remitting EAE in the SJL/J mouse: MOG-reactive transgenic T cells recruit endogenous MOG-specific B cells
por: Pöllinger, Bernadette, et al.
Publicado: (2009)

Novel role for SLPI in MOG-induced EAE revealed by spinal cord expression analysis
por: Mueller, Andre M, et al.
Publicado: (2008)

Oral Tolerance Induction in Experimental Autoimmune Encephalomyelitis with Candida utilis Expressing the Immunogenic MOG35-55 Peptide
por: Buerth, Christoph, et al.
Publicado: (2016)

MOG-expressing teratoma followed by MOG-IgG-positive optic neuritis
por: Wildemann, Brigitte, et al.
Publicado: (2020)

T-cell responses to myelin oligodendrocyte glycoprotein (MOG) in multiple sclerosis
por: Ewing, C., et al.
Publicado: (1998)

Soluble MOG35-55/I-A(b) Dimers Ameliorate Experimental Autoimmune Encephalomyelitis by Reducing Encephalitogenic T Cells
por: Gong, Yeli, et al.
Publicado: (2012)

Evidence of a Muscle–Brain Axis by Quantification of the Neurotrophic Myokine METRNL (Meteorin-Like Protein) in Human Cerebrospinal Fluid and Serum
por: Berghoff, Martin, et al.
Publicado: (2021)

Antibodies to MOG have a demyelination phenotype and affect oligodendrocyte cytoskeleton
por: Dale, Russell C., et al.
Publicado: (2014)

Myelin Oligodendrocyte Glycoprotein (MOG) Optic Neuritis: A Case Series
por: Nurul-Ain, Masnon, et al.
Publicado: (2021)

Quantitative Lipidomic Analysis of Takotsubo Syndrome Patients' Serum
por: Karnati, Srikanth, et al.
Publicado: (2022)

Oligodendrocyte-specific ATF4 inactivation does not influence the development of EAE
por: Yue, Yuan, et al.
Publicado: (2019)

MOG-Specific T Cells Lead to Spontaneous EAE with Multilocular B Cell Infiltration in the GF-IL23 Model
por: Nitsch, Louisa, et al.
Publicado: (2022)

Active induction of experimental autoimmune encephalomyelitis by MOG(35-55) peptide immunization is associated with differential responses in separate compartments of the choroid plexus
por: Murugesan, Nivetha, et al.
Publicado: (2012)

Intractable Hiccup in Demyelinating Disease with Anti-Myelin Oligodendrocyte Glycoprotein (MOG) Antibody
por: Akaishi, Tetsuya, et al.
Publicado: (2016)

Sensory Neurons of the Dorsal Root Ganglia Become Hyperexcitable in a T-Cell-Mediated MOG-EAE Model of Multiple Sclerosis
por: Yousuf, Muhammad Saad, et al.
Publicado: (2019)

Epitope specificity of demyelinating MOG-specific autoantibody responses
por: Brehm, U., et al.
Publicado: (1998)

Attenuation of Immunogenicity in MOG-Induced Oligodendrocytes by the Probiotic Bacterium Lactococcus Sp. PO3
por: Khalifa, Ashraf, et al.
Publicado: (2023)

BMSCs differentiated into neurons, astrocytes and oligodendrocytes alleviated the inflammation and demyelination of EAE mice models
por: Liu, Guo-yi, et al.
Publicado: (2021)

Chronic immobilisation stress ameliorates clinical score and neuroinflammation in a MOG-induced EAE in Dark Agouti rats: mechanisms implicated
por: Pérez-Nievas, Beatriz G, et al.
Publicado: (2010)

Deletion of indoleamine 2,3 dioxygenase (Ido)1 but not Ido2 exacerbates disease symptoms of MOG(35-55)-induced experimental autoimmune encephalomyelitis
por: Wetzel, Lisa A., et al.
Publicado: (2020)

The Expanding Clinical Spectrum of Myelin Oligodendrocyte Glycoprotein (MOG) Antibody Associated Disease in Children and Adults
por: Parrotta, Erica, et al.
Publicado: (2020)

Myelin Oligodendrocyte Glycoprotein (MOG) Antibody Positive Patients in a Multi-Ethnic Canadian Cohort
por: Cross, Helen, et al.
Publicado: (2021)

Myelin Oligodendrocyte Glycoprotein (MOG)-IgG Associated Demyelinating Disease: Our Experience with this Distinct Syndrome
por: Pujari, Shripad S., et al.
Publicado: (2021)

Myelin Oligodendrocyte Glycoprotein (MOG) Antibody Disease in a 11 Year Old with COVID-19 Infection
por: Khan, Archana, et al.
Publicado: (2021)

Infusion of Sulfosuccinimidyl-4-[N-maleimidomethyl]cyclohexane-1-carboxylate-Conjugated MOG(35–55)-Coupled Spleen Cells Effectively Prevents and Reverses Experimental Autoimmune Encephalomyelitis in Mice
por: Zhang, Lanfang, et al.
Publicado: (2015)

HLA-DRα1-mMOG-35-55 treatment of experimental autoimmune encephalomyelitis reduces CNS inflammation, enhances M2 macrophage frequency, and promotes neuroprotection
por: Benedek, Gil, et al.
Publicado: (2015)

A Case of Eosinophilic Granulomatosis With Polyangiitis (EGPA) Peripheral Neuropathy With Positive Anti-Myelin Oligodendrocyte (MOG) Antibodies
por: Yousuf, Kauser, et al.
Publicado: (2023)

Mannan-MOG35-55 Reverses Experimental Autoimmune Encephalomyelitis, Inducing a Peripheral Type 2 Myeloid Response, Reducing CNS Inflammation, and Preserving Axons in Spinal Cord Lesions
por: Dagkonaki, Anastasia, et al.
Publicado: (2020)

CD226 Attenuates Treg Proliferation via Akt and Erk Signaling in an EAE Model
por: Wang, Ning, et al.
Publicado: (2020)

Pattern Visually Evoked Potentials in Japanese Girl With Optic Neuritis and Seropositive to Anti-myelin Oligodendrocyte Glycoprotein (MOG) Antibody
por: Takano, Shunichiro, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_5b94qha0jfg5t892tlei4t0v6f